3-[4,5-bis(4-bromophenyl)-1H-imidazol-2-yl]-2-methyl-1H-indole;4-[2-(5-bromo-1H-indol-3-yl)-5-[4-(methylaminomethyl)phenyl]-1H-imidazol-4-yl]-N,N-dimethylaniline;5-bromo-3-[4-(4-methoxyphenyl)-5-(4-methylphenyl)-1H-imidazol-2-yl]-1H-indole;N,N-dimethyl-4-[5-[4-(methylaminomethyl)phenyl]-2-(2-methyl-1H-indol-3-yl)-1H-imidazol-4-yl]aniline

C104H92Br4N16O — CID 158505337

IUPAC3-[4,5-bis(4-bromophenyl)-1H-imidazol-2-yl]-2-methyl-1H-indole;4-[2-(5-bromo-1H-indol-3-yl)-5-[4-(methylaminomethyl)phenyl]-1H-imidazol-4-yl]-N,N-dimethylaniline;5-bromo-3-[4-(4-methoxyphenyl)-5-(4-methylphenyl)-1H-imidazol-2-yl]-1H-indole;N,N-dimethyl-4-[5-[4-(methylaminomethyl)phenyl]-2-(2-methyl-1H-indol-3-yl)-1H-imidazol-4-yl]aniline
SMILESCNCc1ccc(-c2[nH]c(-c3c(C)[nH]c4ccccc34)nc2-c2ccc(N(C)C)cc2)cc1.CNCc1ccc(-c2[nH]c(-c3c[nH]c4ccc(Br)cc34)nc2-c2ccc(N(C)C)cc2)cc1.COc1ccc(-c2nc(-c3c[nH]c4ccc(Br)cc34)[nH]c2-c2ccc(C)cc2)cc1.Cc1[nH]c2ccccc2c1-c1nc(-c2ccc(Br)cc2)c(-c2ccc(Br)cc2)[nH]1
InChIInChI=1S/C28H29N5.C27H26BrN5.C25H20BrN3O.C24H17Br2N3/c1-18-25(23-7-5-6-8-24(23)30-18)28-31-26(20-11-9-19(10-12-20)17-29-2)27(32-28)21-13-15-22(16-14-21)33(3)4;1-29-15-17-4-6-18(7-5-17)25-26(19-8-11-21(12-9-19)33(2)3)32-27(31-25)23-16-30-24-13-10-20(28)14-22(23)24;1-15-3-5-16(6-4-15)23-24(17-7-10-19(30-2)11-8-17)29-25(28-23)21-14-27-22-12-9-18(26)13-20(21)22;1-14-21(19-4-2-3-5-20(19)27-14)24-28-22(15-6-10-17(25)11-7-15)23(29-24)16-8-12-18(26)13-9-16/h5-16,29-30H,17H2,1-4H3,(H,31,32);4-14,16,29-30H,15H2,1-3H3,(H,31,32);3-14,27H,1-2H3,(H,28,29);2-13,27H,1H3,(H,28,29)
InChIKeyHKKAGXJKKPFLGO-UHFFFAOYSA-N
MW1901.61 g/mol
LogP27.12
Rot. Bonds19

About 3-[4,5-bis(4-bromophenyl)-1H-imidazol-2-yl]-2-methyl-1H-indole;4-[2-(5-bromo-1H-indol-3-yl)-5-[4-(methylaminomethyl)phenyl]-1H-imidazol-4-yl]-N,N-dimethylaniline;5-bromo-3-[4-(4-methoxyphenyl)-5-(4-methylphenyl)-1H-imidazol-2-yl]-1H-indole;N,N-dimethyl-4-[5-[4-(methylaminomethyl)phenyl]-2-(2-methyl-1H-indol-3-yl)-1H-imidazol-4-yl]aniline

3-[4,5-bis(4-bromophenyl)-1H-imidazol-2-yl]-2-methyl-1H-indole;4-[2-(5-bromo-1H-indol-3-yl)-5-[4-(methylaminomethyl)phenyl]-1H-imidazol-4-yl]-N,N-dimethylaniline;5-bromo-3-[4-(4-methoxyphenyl)-5-(4-methylphenyl)-1H-imidazol-2-yl]-1H-indole;N,N-dimethyl-4-[5-[4-(methylaminomethyl)phenyl]-2-(2-methyl-1H-indol-3-yl)-1H-imidazol-4-yl]aniline (PubChem CID 158505337) has the molecular formula C104H92Br4N16O and a molecular weight of 1901.61 g/mol. Its IUPAC name is 3-[4,5-bis(4-bromophenyl)-1H-imidazol-2-yl]-2-methyl-1H-indole;4-[2-(5-bromo-1H-indol-3-yl)-5-[4-(methylaminomethyl)phenyl]-1H-imidazol-4-yl]-N,N-dimethylaniline;5-bromo-3-[4-(4-methoxyphenyl)-5-(4-methylphenyl)-1H-imidazol-2-yl]-1H-indole;N,N-dimethyl-4-[5-[4-(methylaminomethyl)phenyl]-2-(2-methyl-1H-indol-3-yl)-1H-imidazol-4-yl]aniline.

Molecular Properties

Compound Name3-[4,5-bis(4-bromophenyl)-1H-imidazol-2-yl]-2-methyl-1H-indole;4-[2-(5-bromo-1H-indol-3-yl)-5-[4-(methylaminomethyl)phenyl]-1H-imidazol-4-yl]-N,N-dimethylaniline;5-bromo-3-[4-(4-methoxyphenyl)-5-(4-methylphenyl)-1H-imidazol-2-yl]-1H-indole;N,N-dimethyl-4-[5-[4-(methylaminomethyl)phenyl]-2-(2-methyl-1H-indol-3-yl)-1H-imidazol-4-yl]aniline
PubChem CID158505337
Molecular FormulaC104H92Br4N16O
Molecular Weight1901.61 g/mol
Exact Mass1896.44
IUPAC Name3-[4,5-bis(4-bromophenyl)-1H-imidazol-2-yl]-2-methyl-1H-indole;4-[2-(5-bromo-1H-indol-3-yl)-5-[4-(methylaminomethyl)phenyl]-1H-imidazol-4-yl]-N,N-dimethylaniline;5-bromo-3-[4-(4-methoxyphenyl)-5-(4-methylphenyl)-1H-imidazol-2-yl]-1H-indole;N,N-dimethyl-4-[5-[4-(methylaminomethyl)phenyl]-2-(2-methyl-1H-indol-3-yl)-1H-imidazol-4-yl]aniline
SMILESCNCc1ccc(-c2[nH]c(-c3c(C)[nH]c4ccccc34)nc2-c2ccc(N(C)C)cc2)cc1.CNCc1ccc(-c2[nH]c(-c3c[nH]c4ccc(Br)cc34)nc2-c2ccc(N(C)C)cc2)cc1.COc1ccc(-c2nc(-c3c[nH]c4ccc(Br)cc34)[nH]c2-c2ccc(C)cc2)cc1.Cc1[nH]c2ccccc2c1-c1nc(-c2ccc(Br)cc2)c(-c2ccc(Br)cc2)[nH]1
InChIInChI=1S/C28H29N5.C27H26BrN5.C25H20BrN3O.C24H17Br2N3/c1-18-25(23-7-5-6-8-24(23)30-18)28-31-26(20-11-9-19(10-12-20)17-29-2)27(32-28)21-13-15-22(16-14-21)33(3)4;1-29-15-17-4-6-18(7-5-17)25-26(19-8-11-21(12-9-19)33(2)3)32-27(31-25)23-16-30-24-13-10-20(28)14-22(23)24;1-15-3-5-16(6-4-15)23-24(17-7-10-19(30-2)11-8-17)29-25(28-23)21-14-27-22-12-9-18(26)13-20(21)22;1-14-21(19-4-2-3-5-20(19)27-14)24-28-22(15-6-10-17(25)11-7-15)23(29-24)16-8-12-18(26)13-9-16/h5-16,29-30H,17H2,1-4H3,(H,31,32);4-14,16,29-30H,15H2,1-3H3,(H,31,32);3-14,27H,1-2H3,(H,28,29);2-13,27H,1H3,(H,28,29)
InChIKeyHKKAGXJKKPFLGO-UHFFFAOYSA-N
XLogP27.12
TPSA217.65 Ų
H-Bond Donors10
H-Bond Acceptors9
Rotatable Bonds19
Heavy Atoms125
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001901.61
LogP ≤ 527.12
H-Bond Donors ≤ 510
H-Bond Acceptors ≤ 109

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'imidazole_A(19)', 'substructure': 'N/A'}

Analyze 3-[4,5-bis(4-bromophenyl)-1H-imidazol-2-yl]-2-methyl-1H-indole;4-[2-(5-bromo-1H-indol-3-yl)-5-[4-(methylaminomethyl)phenyl]-1H-imidazol-4-yl]-N,N-dimethylaniline;5-bromo-3-[4-(4-methoxyphenyl)-5-(4-methylphenyl)-1H-imidazol-2-yl]-1H-indole;N,N-dimethyl-4-[5-[4-(methylaminomethyl)phenyl]-2-(2-methyl-1H-indol-3-yl)-1H-imidazol-4-yl]aniline with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 3-[4,5-bis(4-bromophenyl)-1H-imidazol-2-yl]-2-methyl-1H-indole;4-[2-(5-bromo-1H-indol-3-yl)-5-[4-(methylaminomethyl)phenyl]-1H-imidazol-4-yl]-N,N-dimethylaniline;5-bromo-3-[4-(4-methoxyphenyl)-5-(4-methylphenyl)-1H-imidazol-2-yl]-1H-indole;N,N-dimethyl-4-[5-[4-(methylaminomethyl)phenyl]-2-(2-methyl-1H-indol-3-yl)-1H-imidazol-4-yl]aniline?
The IUPAC name of 3-[4,5-bis(4-bromophenyl)-1H-imidazol-2-yl]-2-methyl-1H-indole;4-[2-(5-bromo-1H-indol-3-yl)-5-[4-(methylaminomethyl)phenyl]-1H-imidazol-4-yl]-N,N-dimethylaniline;5-bromo-3-[4-(4-methoxyphenyl)-5-(4-methylphenyl)-1H-imidazol-2-yl]-1H-indole;N,N-dimethyl-4-[5-[4-(methylaminomethyl)phenyl]-2-(2-methyl-1H-indol-3-yl)-1H-imidazol-4-yl]aniline (CID 158505337) is 3-[4,5-bis(4-bromophenyl)-1H-imidazol-2-yl]-2-methyl-1H-indole;4-[2-(5-bromo-1H-indol-3-yl)-5-[4-(methylaminomethyl)phenyl]-1H-imidazol-4-yl]-N,N-dimethylaniline;5-bromo-3-[4-(4-methoxyphenyl)-5-(4-methylphenyl)-1H-imidazol-2-yl]-1H-indole;N,N-dimethyl-4-[5-[4-(methylaminomethyl)phenyl]-2-(2-methyl-1H-indol-3-yl)-1H-imidazol-4-yl]aniline.
What is the SMILES notation for 3-[4,5-bis(4-bromophenyl)-1H-imidazol-2-yl]-2-methyl-1H-indole;4-[2-(5-bromo-1H-indol-3-yl)-5-[4-(methylaminomethyl)phenyl]-1H-imidazol-4-yl]-N,N-dimethylaniline;5-bromo-3-[4-(4-methoxyphenyl)-5-(4-methylphenyl)-1H-imidazol-2-yl]-1H-indole;N,N-dimethyl-4-[5-[4-(methylaminomethyl)phenyl]-2-(2-methyl-1H-indol-3-yl)-1H-imidazol-4-yl]aniline?
The canonical SMILES for 3-[4,5-bis(4-bromophenyl)-1H-imidazol-2-yl]-2-methyl-1H-indole;4-[2-(5-bromo-1H-indol-3-yl)-5-[4-(methylaminomethyl)phenyl]-1H-imidazol-4-yl]-N,N-dimethylaniline;5-bromo-3-[4-(4-methoxyphenyl)-5-(4-methylphenyl)-1H-imidazol-2-yl]-1H-indole;N,N-dimethyl-4-[5-[4-(methylaminomethyl)phenyl]-2-(2-methyl-1H-indol-3-yl)-1H-imidazol-4-yl]aniline is CNCc1ccc(-c2[nH]c(-c3c(C)[nH]c4ccccc34)nc2-c2ccc(N(C)C)cc2)cc1.CNCc1ccc(-c2[nH]c(-c3c[nH]c4ccc(Br)cc34)nc2-c2ccc(N(C)C)cc2)cc1.COc1ccc(-c2nc(-c3c[nH]c4ccc(Br)cc34)[nH]c2-c2ccc(C)cc2)cc1.Cc1[nH]c2ccccc2c1-c1nc(-c2ccc(Br)cc2)c(-c2ccc(Br)cc2)[nH]1.
What is the InChIKey of 3-[4,5-bis(4-bromophenyl)-1H-imidazol-2-yl]-2-methyl-1H-indole;4-[2-(5-bromo-1H-indol-3-yl)-5-[4-(methylaminomethyl)phenyl]-1H-imidazol-4-yl]-N,N-dimethylaniline;5-bromo-3-[4-(4-methoxyphenyl)-5-(4-methylphenyl)-1H-imidazol-2-yl]-1H-indole;N,N-dimethyl-4-[5-[4-(methylaminomethyl)phenyl]-2-(2-methyl-1H-indol-3-yl)-1H-imidazol-4-yl]aniline?
The InChIKey is HKKAGXJKKPFLGO-UHFFFAOYSA-N. The full InChI is InChI=1S/C28H29N5.C27H26BrN5.C25H20BrN3O.C24H17Br2N3/c1-18-25(23-7-5-6-8-24(23)30-18)28-31-26(20-11-9-19(10-12-20)17-29-2)27(32-28)21-13-15-22(16-14-21)33(3)4;1-29-15-17-4-6-18(7-5-17)25-26(19-8-11-21(12-9-19)33(2)3)32-27(31-25)23-16-30-24-13-10-20(28)14-22(23)24;1-15-3-5-16(6-4-15)23-24(17-7-10-19(30-2)11-8-17)29-25(28-23)21-14-27-22-12-9-18(26)13-20(21)22;1-14-21(19-4-2-3-5-20(19)27-14)24-28-22(15-6-10-17(25)11-7-15)23(29-24)16-8-12-18(26)13-9-16/h5-16,29-30H,17H2,1-4H3,(H,31,32);4-14,16,29-30H,15H2,1-3H3,(H,31,32);3-14,27H,1-2H3,(H,28,29);2-13,27H,1H3,(H,28,29).
What are the key properties of 3-[4,5-bis(4-bromophenyl)-1H-imidazol-2-yl]-2-methyl-1H-indole;4-[2-(5-bromo-1H-indol-3-yl)-5-[4-(methylaminomethyl)phenyl]-1H-imidazol-4-yl]-N,N-dimethylaniline;5-bromo-3-[4-(4-methoxyphenyl)-5-(4-methylphenyl)-1H-imidazol-2-yl]-1H-indole;N,N-dimethyl-4-[5-[4-(methylaminomethyl)phenyl]-2-(2-methyl-1H-indol-3-yl)-1H-imidazol-4-yl]aniline?
3-[4,5-bis(4-bromophenyl)-1H-imidazol-2-yl]-2-methyl-1H-indole;4-[2-(5-bromo-1H-indol-3-yl)-5-[4-(methylaminomethyl)phenyl]-1H-imidazol-4-yl]-N,N-dimethylaniline;5-bromo-3-[4-(4-methoxyphenyl)-5-(4-methylphenyl)-1H-imidazol-2-yl]-1H-indole;N,N-dimethyl-4-[5-[4-(methylaminomethyl)phenyl]-2-(2-methyl-1H-indol-3-yl)-1H-imidazol-4-yl]aniline has a molecular weight of 1901.61 g/mol, XLogP of 27.12, 19 rotatable bonds, 10 hydrogen bond donors, and 9 hydrogen bond acceptors.
Where does this data come from?
All data for 3-[4,5-bis(4-bromophenyl)-1H-imidazol-2-yl]-2-methyl-1H-indole;4-[2-(5-bromo-1H-indol-3-yl)-5-[4-(methylaminomethyl)phenyl]-1H-imidazol-4-yl]-N,N-dimethylaniline;5-bromo-3-[4-(4-methoxyphenyl)-5-(4-methylphenyl)-1H-imidazol-2-yl]-1H-indole;N,N-dimethyl-4-[5-[4-(methylaminomethyl)phenyl]-2-(2-methyl-1H-indol-3-yl)-1H-imidazol-4-yl]aniline is sourced from PubChem (CID 158505337), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).